Condition: Hyperkalemia · Sponsor: Comprehensive Research Associates
When a patient arrives to an emergency department and is found to have an elevated potassium level in the blood, there is no one standardized treatment, therefore it is not known if one treatment is superior to other. The purpose of this study is to help determine if a drug called patiromer (already approved by the FDA) can help lower potassium levels while patients are in the emergency department.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Stanford University School of Medicine | Stanford, California, United States | — |
| Yale University | New Haven, Connecticut, United States | — |
| Christiana Care | Newark, Delaware, United States | — |
| George Washington University | Washington D.C., District of Columbia, United States | — |
| Baystate Medical Center | Springfield, Massachusetts, United States | — |
| Wayne State University | Detroit, Michigan, United States | — |
| Henry Ford Hospital | Detroit, Michigan, United States | — |
| Hennepin Healthcare Research Institute | Minneapolis, Minnesota, United States | — |
| University of Mississippi Medical Center | Jackson, Mississippi, United States | — |
| Washington University of St Louis | St Louis, Missouri, United States | — |
| Mt Sinai. Icahn School of Medicine | New York, New York, United States | — |
| Maimonides Medical Center | New York, New York, United States | — |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04443608